Blood, serum, and plasma

The MATCH Study of HIV and Aging

  • Principal Investigator(s): Monty Montano
  • Study Contact: Brooke Ferguson Brawley; BBRAWLEY@PARTNERS.ORG617-525-9195
  • Description of Subjects: Adult males and females, 50-65 years old. If HIV+, on effective ART.
  • Location (Domestic vs. International): Boston Metropolitan Area
  • Enrollment Period: 2015-2016
  • Enrollment Goal: 200

Cotrimoxazole safety study

  • Principal Investigator(s): Scott Dryden-Peterson
  • Study Contact: Scott Dryden-Peterson, +2.677.447.2522, scott_peterson@post.harvard.edu
  • Description of Subjects: Infants born to HIV-infected women
  • Location (Domestic vs. International): Botswana
  • Enrollment Period: 2008-2009
  • Enrollment Goal: 444 mother-infant pairs

HIV Research Network (HIVRN)

  • Principal Investigator(s): Stephen Boswell, MD
  • Study Contact: Sarah Wolfrum, DrPH, 617-927-6367, swolfrum@fenwayhealth.org
  • Description of Subjects: HIV-infected patients aged 18 and older receiving medical care at Fenway Health. (HIVRN includes pediatric data, but Fenway Health only submits adult patient data)
    • HIV+
    • HIV/HCV Co-infected

Uganda AIDS Rural Treatment Outcomes Cohort Study

  • Principal Investigator(s): David Bangsberg, MD
  • Study Contact: Rachel Rifkin617.724.3194rrifkin@partners.org
  • Description of Subjects: All patients over 18 years and initiating ART at the Mbarara Immune Suppression Syndrome Clinic who lived within 60 kilometers from the clinic
  • Location (Domestic vs. International): Mbarara, Uganda

CFAR Network of Integrated Clinical Systems (C-NICS)

  • Principal Investigator(s): Stephen Boswell, MD
  • Study Contact: Chris Grasso, Tel: 617-927-6018, cgrasso@fenwayhealth.org
  • Description of Subjects: HIV infected patients receiving primary care at Fenway Health. HIV+, HIV Co-infected
  • Location (Domestic vs. International): Fenway Health: Boston, MA
  • Enrollment Period: 1997 to present (ongoing)

Effect on CNS with ART switch off EFV-based therapy

  • Principal Investigator(s): Nina LIn
  • Study Contact:  Nina Lin, Tel: 617-768-8479, nhlin@partners.org
  • Description of Subjects:  Effect on CNS with ART switch off EFV-based therapy
  • Location (Domestic vs. International): Domestic, BWH (recruiting can be from MGH or BIDMC)
  • Enrollment Period: Beginning January 2014

HIV and Aging Cohort Study

  • Principal Investigator(s): Nina Lin
  • Study Contact:  Nina Lin, Tel: 617-768-8479, nhlin@partners.org
  • Description of Subjects:  HIV+ on ART who are </= 35 yo or >/=50yo with no hepatitis co-infection
  • Location (Domestic vs. International): Domestic, BWH, BIDMC, MGH
  • Enrollment Period: 2011-present
  • Enrollment Goal: 

Pediatric HIV/AIDS Cohort Study (PHACS -BCH site only)

  • Principal Investigator(s): Sandra Burchett (site leader), George Seage PI
  • Study Contact: Sandra Burchett, MD, Tel. 617 355-6832, sandra.burchett@childrens.harvard.edu
  • Description of Subjects: AMP:450 HIV+ youth, 150 HIV-controls; SMARRT: >1700 HIV neg/ARV exposed infants,youth. Study domains: cardiopulm, metabol, complications and HIV disease, maternal exposures, neuro, oral health, adolescent

Mothers and Infants Botswana PMTCT trial

  • Principal Investigator(s): Roger Shapiro
  • Study Contact: Roger Shapiro, 617-771-0040,rshapiro@hsph.harvard.edu
  • Description of Subjects: 730 mothers and infants in a Botswana PMTCT trial
  • Location (Domestic vs. International): International, Botswana
  • Enrollment Period: 2006-2008
  • Enrollment Goal: 730

Pages